Study Stopped
Repeated application of the same project
Prediction Model of Spontaneous Closure of Congenital Perimembranous Ventricular Septal Defects
Study on the Predicting Model for Spontaneous Closure of Perimembranous Ventricular Septal Defects in Children- An Observational Research Based on the Real World
1 other identifier
observational
N/A
1 country
1
Brief Summary
The objective of this study is to establish a more comprehensive model for evaluating the condition of children with ventricular septal defect and predicting the probability and time of their spontaneous Closure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Oct 2020
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedFirst Posted
Study publicly available on registry
August 3, 2026
CompletedAugust 3, 2026
August 1, 2020
1.2 years
August 26, 2020
July 31, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of participants with spontaneous closure of perimembranous ventricular septal defect confirmed by echocardiography
Spontaneous closure is defined as the absence of a ventricular septal defect shunt on color Doppler echocardiography, without prior surgical or transcatheter closure intervention.
From baseline to December 2022
Study Arms (2)
PMVSD spontaneously closed group
Echocardiography diagnosis of PMVSD spontaneous closure
PMVSD unclosed group
Including defect reduction group and surgery group
Eligibility Criteria
PMVSD children aged 0 to 14
You may qualify if:
- The initial diagnosis age is from birth to 14 years old
- Ultrasonography confirmed the presence of simple PMVSD or other simple congenital heart diseases without other complicated heart malformations (such as pulmonary venous drainage, conus trunk malformation, interruption of aortic arch, primary pulmonary hypertension, etc.)
- No major disease at first diagnosis (life-threatening organic disease not caused by congenital heart disease)
- The patient or guardian voluntarily signs the informed consent form
You may not qualify if:
- The initial diagnosis age\>14 years old.
- With complicated congenital heart disease (such as pulmonary venous ectopic drainage, conus trunk malformation, interruption of aortic arch, primary pulmonary hypertension, etc.)
- Serious diseases of other organs
- Unable to cooperate with the doctor to complete regular outpatient follow-up or give up treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pengjun Zhao, MD
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor of Department of Pediatric Cardiology
Study Record Dates
First Submitted
August 26, 2020
First Posted
August 3, 2026
Study Start
October 1, 2020
Primary Completion
December 30, 2021
Study Completion
December 30, 2022
Last Updated
August 3, 2026
Record last verified: 2020-08